Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Each vial contains 40mg of Retatrutide as a lyophilised powder, sealed and independently assayed to 99% purity
Safer options include medically supervised GLP-1 therapy, nutritional counseling, cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and holistic approaches like mindfulness-based stress reduction
GLP-1 receptor activation reduces appetite centrally (through the hypothalamus and brainstem), slows gastric emptying, and enhances glucose-dependent insulin secretion
Emerging agents like Tirzepatide, which activates both GLP-1 and GIP receptors, and Orforglipron, a nonpeptide oral GLP-1 agonist in phase 2 trials, further expand the therapeutic potential of this class (23)(24)
Sodium-glucose transport protein 2 (SGLT2) inhibitors
Please Hold Non-Urgent Questions We understand these changes may feel frustrating or uncertain, and we are committed to guiding you through them
US$ 21.24
US$ 25.04
US$ 24.56
US$ 21.49
US$ 28.05
US$ 24.31
